scispace - formally typeset
R

Roger L. Jenkins

Researcher at Lahey Hospital & Medical Center

Publications -  119
Citations -  6070

Roger L. Jenkins is an academic researcher from Lahey Hospital & Medical Center. The author has contributed to research in topics: Liver transplantation & Transplantation. The author has an hindex of 43, co-authored 119 publications receiving 5891 citations. Previous affiliations of Roger L. Jenkins include Tufts University.

Papers
More filters
Journal ArticleDOI

Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome.

TL;DR: Surgical resection or cryotherapy of hepatic metastasis from colorectal cancer is safe and curable in appropriately selected patients and surgical margin governs the patterns of failure and outcome in potentially curable patients.
Journal ArticleDOI

Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases.

TL;DR: Intraoperative liver examination by ultrasound during primary colon cancer resection and adjuvant chemotherapy may offer earlier selection of biologically appropriate patients and improved outcome; both recommendations require clinical trials.
Journal ArticleDOI

A 5-year study of cryosurgery in the treatment of liver tumors.

TL;DR: The long-term effectiveness of cryosurgery in the treatment of primary and metastatic liver tumors is established, with patterns of failure included liver and extrahepatic disease in 54% of cases, liver disease only in 32% of Cases, and extra hematological disease onlyIn patients with "liver only" failure, recurrence at the treatment site occurred in three patients
Journal ArticleDOI

Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial.

TL;DR: A randomized, multicenter, placebo-controlled, double-blind trial ofCMV disease prevention in liver transplant recipients, testing the hypothesis that the rate of CMV disease could be reduced by 50% in globulin recipients.
Journal Article

Cytomegalovirus Immune Globulin Prophylaxis in Liver Transplantation

TL;DR: In this article, the authors studied the effect of cytomegalovirus immune globulin (CMVIG) on prevention of CMV disease and its complications in patients receiving liver transplants.